Dynamic Technology Lab Private LTD Immunovant, Inc. Transaction History

Dynamic Technology Lab Private LTD

  • $914 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$30.27 - $43.79 $534,870 - $773,769
17,670 New
17,670 $571,000
Q1 2023

May 12, 2023
BUY
$15.27 - $19.72 $448,678 - $579,432
29,383 New
29,383 $456,000
Q4 2021

Feb 14, 2022
SELL
$7.33 - $9.32 $127,366 - $161,944
-17,376 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$7.01 - $11.37 $16,445 - $26,674
-2,346 Reduced 11.9%
17,376 $151,000
Q2 2021

Aug 13, 2021
BUY
$9.4 - $16.85 $185,386 - $332,315
19,722 New
19,722 $208,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email